Literature DB >> 21843076

Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities.

Sergio A Quezada, Karl S Peggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21843076     DOI： 10.2217/imt.11.83

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  7 in total

1.  Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.

Authors:  Jacques Thibodeau; Marie-Claude Bourgeois-Daigneault; Réjean Lapointe
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

2.  Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.

Authors:  Jochen Belmans; Matthias Van Woensel; Brecht Creyns; Joost Dejaegher; Dominique M Bullens; Stefaan W Van Gool
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

3.  Citrullinated α-enolase is an effective target for anti-cancer immunity.

Authors:  Katherine Cook; Ian Daniels; Peter Symonds; Tracy Pitt; Mohamed Gijon; Wei Xue; Rachael Metheringham; Lindy Durrant; Victoria Brentville
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

Review 4.  PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.

Authors:  Michal Šmahel
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

5.  Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.

Authors:  Victoria A Brentville; Rachael L Metheringham; Ian Daniels; Suha Atabani; Peter Symonds; Katherine W Cook; Mireille Vankemmelbeke; Ruhul Choudhury; Poonam Vaghela; Mohamed Gijon; Ghislaine Meiners; Willem-Jan Krebber; Cornelis J M Melief; Lindy G Durrant
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

6.  MHCII Expression on Peripheral Blood Monocytes in Canine Lymphoma: An Impact of Glucocorticoids.

Authors:  Alicja Rzepecka; Dariusz Jagielski; Anna Cywińska; Rafał Sapierzyński; Magdalena Żmigrodzka; Olga Witkowska-Piłaszewicz; Anna Winnicka
Journal:  Animals (Basel)       Date:  2022-08-19       Impact factor: 3.231

7.  Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.

Authors:  Katherine W Cook; Wei Xue; Peter Symonds; Ian Daniels; Mohamed Gijon; David Boocock; Clare Coveney; Amanda K Miles; Sabaria Shah; Suha Atabani; Ruhul H Choudhury; Poonam Vaghela; Daisy Weston; Rachael L Metheringham; Victoria A Brentville; Lindy G Durrant
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.